The STAT3 transcription factor is frequently activated in NHL, regulating cell survival and proliferation, and has been associated with poor survival of patients with aggressive lymphoma.5, 6, 7, 8, 9 Mutations of upstream STAT3 regulators are common in DLBCL.10 The gene discussed is STAT3; the disease is non-Hodgkin lymphoma.